182 related articles for article (PubMed ID: 26405806)
1. TAT Modification of Alpha-Helical Anticancer Peptides to Improve Specificity and Efficacy.
Hao X; Yan Q; Zhao J; Wang W; Huang Y; Chen Y
PLoS One; 2015; 10(9):e0138911. PubMed ID: 26405806
[TBL] [Abstract][Full Text] [Related]
2. Synergistic effect of the pro-apoptosis peptide kla-TAT and the cationic anticancer peptide HPRP-A1.
Hu C; Chen X; Huang Y; Chen Y
Apoptosis; 2018 Feb; 23(2):132-142. PubMed ID: 29397453
[TBL] [Abstract][Full Text] [Related]
3. Co-administration of iRGD with peptide HPRP-A1 to improve anticancer activity and membrane penetrability.
Hu C; Chen X; Huang Y; Chen Y
Sci Rep; 2018 Feb; 8(1):2274. PubMed ID: 29396568
[TBL] [Abstract][Full Text] [Related]
4. Targeted Modification of the Cationic Anticancer Peptide HPRP-A1 with iRGD To Improve Specificity, Penetration, and Tumor-Tissue Accumulation.
Hu C; Huang Y; Chen Y
Mol Pharm; 2019 Feb; 16(2):561-572. PubMed ID: 30592418
[TBL] [Abstract][Full Text] [Related]
5. Anticancer activity of Helicobacter pylori ribosomal protein (HPRP) with iRGD in treatment of colon cancer.
Yaghoubi A; Asgharzadeh F; Movaqar A; Ghazvini K; Hassanian SM; Avan A; Khazaei M; Soleimanpour S
J Cancer Res Clin Oncol; 2021 Oct; 147(10):2851-2865. PubMed ID: 34117917
[TBL] [Abstract][Full Text] [Related]
6. Two hits are better than one: synergistic anticancer activity of α-helical peptides and doxorubicin/epirubicin.
Zhao J; Huang Y; Liu D; Chen Y
Oncotarget; 2015 Jan; 6(3):1769-78. PubMed ID: 25593197
[TBL] [Abstract][Full Text] [Related]
7. Cell penetrating peptide TAT can kill cancer cells via membrane disruption after attachment of camptothecin.
Song J; Zhang Y; Zhang W; Chen J; Yang X; Ma P; Zhang B; Liu B; Ni J; Wang R
Peptides; 2015 Jan; 63():143-9. PubMed ID: 25496911
[TBL] [Abstract][Full Text] [Related]
8. Coadministration of kla peptide with HPRP-A1 to enhance anticancer activity.
Hao W; Hu C; Huang Y; Chen Y
PLoS One; 2019; 14(11):e0223738. PubMed ID: 31703065
[TBL] [Abstract][Full Text] [Related]
9. The global gene-expression profiles of U-937 human macrophages treated with Tat peptide and Tat-FITC conjugate.
Lin CW; Kuo JH; Jan MS
J Drug Target; 2012 Jul; 20(6):515-23. PubMed ID: 22632162
[TBL] [Abstract][Full Text] [Related]
10. In vitro Characterization of the Rapid Cytotoxicity of Anticancer Peptide HPRP-A2 through Membrane Destruction and Intracellular Mechanism against Gastric Cancer Cell Lines.
Zhao J; Hao X; Liu D; Huang Y; Chen Y
PLoS One; 2015; 10(9):e0139578. PubMed ID: 26422386
[TBL] [Abstract][Full Text] [Related]
11. TAT-Modified Gold Nanoparticles Enhance the Antitumor Activity of PAD4 Inhibitors.
Song S; Gui L; Feng Q; Taledaohan A; Li Y; Wang W; Wang Y; Wang Y
Int J Nanomedicine; 2020; 15():6659-6671. PubMed ID: 32982225
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of intracellular delivery of anti-cancer drugs by the Tat peptide.
Zhao JF; Chen JY; Mi L; Wang PN; Peng Q
Ultrastruct Pathol; 2011 May; 35(3):119-23. PubMed ID: 21405950
[TBL] [Abstract][Full Text] [Related]
13. A novel peptide from alpha5 helix of Asterina pectinifera cyclin B conjugated to HIV-Tat(49-57) with cytotoxic and apoptotic effects against human cancer cells.
Lou H; Gao Y; Zhai M; Qi Y; Chen L; Lv H; Yu J; Li Y
Bioorg Med Chem Lett; 2008 Aug; 18(16):4633-7. PubMed ID: 18656352
[TBL] [Abstract][Full Text] [Related]
14. A novel cell-penetrating peptide TAT-A1 delivers siRNA into tumor cells selectively.
Fang B; Jiang L; Zhang M; Ren FZ
Biochimie; 2013 Feb; 95(2):251-7. PubMed ID: 23009929
[TBL] [Abstract][Full Text] [Related]
15. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
[TBL] [Abstract][Full Text] [Related]
16. Research on the effect and mechanism of antimicrobial peptides HPRP-A1/A2 work against Toxoplasma gondii infection.
Liu R; Ni Y; Song J; Xu Z; Qiu J; Wang L; Zhu Y; Huang Y; Ji M; Chen Y
Parasite Immunol; 2019 May; 41(5):e12619. PubMed ID: 30788848
[TBL] [Abstract][Full Text] [Related]
17. Oligopeptides derived from autophosphorylation sites of EGF receptor suppress EGF-stimulated responses in human lung carcinoma A549 cells.
Kuroda Y; Kato-Kogoe N; Tasaki E; Murata E; Ueda K; Abe M; Miyamoto K; Nakase I; Futaki S; Tohyama Y; Hirose M
Eur J Pharmacol; 2013 Jan; 698(1-3):87-94. PubMed ID: 23085023
[TBL] [Abstract][Full Text] [Related]
18. Improved tumor targetability of Tat-conjugated PAMAM dendrimers as a novel nanosized anti-tumor drug carrier.
Yan C; Gu J; Hou D; Jing H; Wang J; Guo Y; Katsumi H; Sakane T; Yamamoto A
Drug Dev Ind Pharm; 2015 Apr; 41(4):617-22. PubMed ID: 24564798
[TBL] [Abstract][Full Text] [Related]
19. Co-administration of kla-TAT peptide and iRGD to enhance the permeability on A549 3D multiple sphere cells and accumulation on xenograft mice.
Hu C; Chen X; Huang Y; Chen Y
Chem Biol Drug Des; 2018 Aug; 92(2):1567-1575. PubMed ID: 29722179
[TBL] [Abstract][Full Text] [Related]
20. HIV-TAT-fused FHIT protein functions as a potential pro-apoptotic molecule in hepatocellular carcinoma cells.
Yu GR; Qin WW; Li JP; Hua W; Meng YL; Chen R; Yan B; Wang L; Zhang X; Jia LT; Zhao J; Zhang R; Yang AG
Biosci Rep; 2012 Jun; 32(3):271-9. PubMed ID: 21679157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
